Article Details

Caladrius Biosciences (NASDAQ:CLBS) Price Target Raised to $10.00 at Brookline Capital ...

Retrieved on: 2021-03-09 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

Caladrius Biosciences (NASDAQ:CLBS) Price Target Raised to $10.00 at Brookline Capital .... View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 156,668 shares of the biotechnology company's stock worth $282,000 after purchasing an additional 85,146 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up